SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-08-002714
Filing Date
2008-05-27
Accepted
2008-05-27 16:30:57
Documents
4
Period of Report
2008-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_27392.htm 8-K 18482
2 EX-10.1 exhibit1.htm EX-10.1 8513
3 EX-10.2 exhibit2.htm EX-10.2 33749
4 EX-99.1 exhibit3.htm EX-99.1 6819
  Complete submission text file 0001299933-08-002714.txt   69190
Mailing Address 125 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 125 SIDNEY STREET CAMBRIDGE MA 02139 617-299-2900
Altus Pharmaceuticals Inc. (Filer) CIK: 0001340744 (see all company filings)

IRS No.: 043573277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51711 | Film No.: 08861072
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1